DNA methylation in inflammatory bowel disease and beyond

Area of Science:

• Genetics
• Epigenetics
• Gastroenterology

Background:

• Inflammatory bowel disease (IBD) arises from complex interactions between host genetics, environment, and gut microbiota.
• Genome-wide association studies (GWAS) have identified some IBD susceptibility genes, but many cases remain unexplained.
• DNA methylation, a key epigenetic modification, is increasingly recognized for its role in IBD pathogenesis.

Purpose of the Study:

• To review recent advancements in understanding the contribution of DNA methylation alterations to IBD development.
• To highlight the mechanistic role of DNA methylation in IBD pathogenesis.
• To discuss the implications of DNA methylation changes throughout the lifespan in IBD.

Main Methods:

• Review of current literature on DNA methylation and IBD.
• Analysis of studies investigating epigenetic modifications in IBD.
• Synthesis of findings on the link between DNA methylation and gene expression in IBD.

Main Results:

• DNA methylation alterations are implicated in the development of IBD.
• These epigenetic changes can directly influence gene expression relevant to IBD.
• Alterations in DNA methylation may occur early in development and persist throughout life.

Conclusions:

• DNA methylation is a critical factor in IBD pathogenesis, offering potential new avenues for research.
• Further investigation into DNA methylation patterns can help elucidate the genetic underpinnings of IBD.
• Understanding epigenetic modifications is essential for a comprehensive view of IBD development.